EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Cytomorphology, Immunophenotype, and Molecular Genetics of Lymphoblastic Lymphoma/Leukemia in Serous Effusion

Wenjing Cui, Xiaochen Ding, Jiayan Liu, Peizhen Hu, Shirong Ma, Changwei Yang, Hong Xu

Acta Cytologica · 2025

DOI: 10.1159/000548726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Cytologica, 2025. Verfasst von Wenjing Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, Xijing Hospital, Fourth Military Medica…. Hauptthemen laut MEDLINE: Immunophenotyping, Biomarkers, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Pleural Effusion, Malignant. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to elucidate the spectrum of clinical manifestations, cytomorphology, immunophenotype, and the molecular genetic features of lymphoblastic lymphoma/acute lymphoblastic leukemia (LBL/ALL) in the context of serous effusions (SE).

Methods

A retrospective analysis evaluated the cytomorphological features, immunophenotype, and the cyto-histological correlations of twenty-one LBL/ALL associated with SE. Concurrently, bone marrow (BM) aspiration samples were analyzed using an integrated approach, including flow cytometry, reverse transcription PCR (RT-PCR), next-generation sequencing (NGS), or whole transcriptome sequencing (WTS).

Results

Of the 21 cases of SE LBL/ALL, 16 cases were T-LBL/ALL and 5 cases were B-LBL/ALL. The cases included 17 pleural, 2 peritoneal, and 2 pericardial fluid samples. Both T-LBL/ALL and B-LBL/ALL in SE exhibit a blast-like morphology, characterized by small to medium size, irregular nuclear membranes, and inconspicuous nucleoli, alongside frequent nuclear fragmentation and apoptotic bodies. LBL/ALL express immaturity markers such as terminal deoxynucleotidyl transferase (7/17, 41.2%), CD10 (6/12, 50%), CD43 (8/8, 100%), and CD99 (6/6, 100%). T-LBL/ALL and B-LBL/ALL specifically express T-cell markers (CD2 [3/6, 50%], CD3 [10/12, 83.3%], CD5 [2/11, 18.2%], CD7 [10/10, 100%]) or B-cell markers (CD20 [3/5, 60%], CD79a [4/4, 100%], PAX5 [5/5, 100%]), respectively. A high proportion of primitive and immature lymphocytes exceeding 25% in BM was observed in T-LBL/ALL (5/7) and in one case of B-LBL/ALL. No BCR/ABL gene rearrangements were detected in any cases. Furthermore, fusion gene MLL::ENL and PLCALM::MLLT10, as well as mutations in genes including WT1, NOTCH1, PAX5, IKZF, ARID1A, BCOR, SETD2, ARID2, TET2, JAK3, NF1, and CEBPA, were identified in LBL/ALL through RT-PCR, NGS, or WTS analyses.

Conclusion

The integration of clinical manifestations, cytological evaluation, and gene expression profiles is instrumental in achieving accurate diagnosis, subclassification, and prognosis of LBL/ALL within the context of SE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunophenotypingBiomarkers, TumorPrecursor Cell Lymphoblastic Leukemia-LymphomaPleural Effusion, MalignantPericardial EffusionAscitic FluidHumansFemaleMaleRetrospective StudiesAdultMiddle AgedAdolescentYoung AdultAgedChildHigh-Throughput Nucleotide SequencingFlow CytometryChild, PreschoolPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma

Stichwörter der Autor:innen

CytologyImmunocytochemistryLymphoblastic lymphoma/leukemiaMolecular geneticsSerous effusion

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Experimental Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Emergency, Honghui Hospital, School of Medicine, Xi'an Jiao Tong University, Xi'an, China, 1468026834@qq.com.
  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, China, nba0128@163.com.

Zitieren

APA

Cui, W., Ding, X., Liu, J., Hu, P., Ma, S., Yang, C., & Xu, H. (2025). Evaluation of the Cytomorphology, Immunophenotype, and Molecular Genetics of Lymphoblastic Lymphoma/Leukemia in Serous Effusion. Acta Cytologica. https://doi.org/10.1159/000548726

Vancouver

Cui W, Ding X, Liu J, Hu P, Ma S, Yang C, et al. Evaluation of the Cytomorphology, Immunophenotype, and Molecular Genetics of Lymphoblastic Lymphoma/Leukemia in Serous Effusion. Acta Cytologica. 2025. doi:10.1159/000548726

BibTeX
@article{Cui2025,
  author = {Cui, Wenjing and Ding, Xiaochen and Liu, Jiayan and Hu, Peizhen and Ma, Shirong and Yang, Changwei and Xu, Hong},
  title = {Evaluation of the Cytomorphology, Immunophenotype, and Molecular Genetics of Lymphoblastic Lymphoma/Leukemia in Serous Effusion},
  journal = {Acta Cytologica},
  year = {2025},
  doi = {10.1159/000548726}
}
Kostenlos starten →